SEARCH

SEARCH BY CITATION

References

  • 1
    Denis MM, Tolley ND, Bunting M et al. Escaping the nuclear confines: Signal-dependent pre-mRNA splicing in anucleate platelets. Cell 2005; 122: 379391.
  • 2
    Schwertz H, Tolley ND, Foulks JM et al. Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets. J Exp Med 2006; 203: 24332440.
  • 3
    Elzey BD, Sprague DL, Ratliff TL. The emerging role of platelets in adaptive immunity. Cell Immunol 2005; 238: 19.
  • 4
    Langer H, May AE, Daub K et al. Adherent platelets recruit and induce differentiation of murine embryonic endothelial progenitor cells to mature endothelial cells in vitro. Circ Res 2006; 98: e2–e10.
  • 5
    Massberg S, Konrad I, Schurzinger K et al. Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J Exp Med 2006; 203: 12211233.
  • 6
    Burger PC, Wagner DD. Platelet P-selectin facilitates atherosclerotic lesion development. Blood 2003; 101: 26612666.
  • 7
    Porter KA. Morphological aspects of renal homograft rejection. Br Med Bull 1965; 21: 171175.
  • 8
    Oluwole S, Wang T, Fawwaz R et al. Use of indium-111-labeled cells in measurement of cellular dynamics of experimental cardiac allograft rejection. Transplantation 1981; 31: 5155.
  • 9
    Halloran PF, Wadgymar A, Ritchie S, Falk J, Solez K, Srinivasa NS. The significance of the anti-class I antibody response. I. Clinical and pathologic features of anti-class I-mediated rejection. Transplantation 1990; 49: 8591.
  • 10
    Qian Z, Wasowska BA, Behrens E et al. C6 produced by macrophages contributes to cardiac allograft rejection. Am J Pathol 1999; 155: 12931302.
  • 11
    Nakashima S, Qian Z, Rahimi S, Wasowska BA, Baldwin WM, III. Membrane attack complex contributes to destruction of vascular integrity in acute lung allograft rejection. J Immunol 2002; 169: 46204627.
  • 12
    Ota H, Fox-Talbot K, Hu W et al. Terminal complement components mediate release of von Willebrand factor and adhesion of platelets in arteries of allografts. Transplantation 2005; 79: 276281.
  • 13
    Xu H, Zhang X, Mannon RB, Kirk AD. Platelet-derived or soluble CD154 induces vascularized allograft rejection independent of cell-bound CD154. J Clin Invest 2006; 116: 769774.
  • 14
    Shrivastava S, McVey JH, Dorling A. The interface between coagulation and immunity. Am J Transplant 2007; 7: 499506.
  • 15
    Dwyer KM, Robson SC, Nandurkar HH et al. Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation. J Clin Invest 2004; 113: 14401446.
  • 16
    Robson SC, Wu Y, Sun X, Knosalla C, Dwyer K, Enjyoji K. Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation. Semin Thromb Hemost 2005; 31: 217233.
  • 17
    Padilla A, Moake JL, Bernardo A et al. P-selectin anchors newly released ultralarge von Willebrand factor multimers to the endothelial cell surface. Blood 2004; 103: 21502156.
  • 18
    Argenbright LW, Barton RW. Interactions of leukocyte integrins with intercellular adhesion molecule 1 in the production of inflammatory vascular injury in vivo. The Shwartzman reaction revisited. J Clin Invest 1992; 89: 259272.
  • 19
    Huo Y, Schober A, Forlow SB et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 2003; 9: 6167.
  • 20
    Dole VS, Bergmeier W, Mitchell HA, Eichenberger SC, Wagner DD. Activated platelets induce Weibel-Palade-body secretion and leukocyte rolling in vivo: Role of P-selectin. Blood 2005; 106: 23342339.
  • 21
    Laposata M, Krueger CM, Saffitz JE. Selective uptake of [3H]arachidonic acid into the dense tubular system of human platelets. Blood 1987; 70: 832837.
  • 22
    Rocca B, Secchiero P, Ciabattoni G et al. Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets. Proc Natl Acad Sci USA 2002; 99: 76347639.
  • 23
    Rocha PN, Plumb TJ, Crowley SD, Coffman TM. Effector mechanisms in transplant rejection. Immunol Rev 2003; 196: 5164.
  • 24
    Thomas DW, Rocha PN, Nataraj C et al. Proinflammatory actions of thromboxane receptors to enhance cellular immune responses. J Immunol 2003; 171: 63896395.
  • 25
    Goulet JL, Griffiths RC, Ruiz P et al. Deficiency of 5-lipoxygenase accelerates renal allograft rejection in mice. J Immunol 2001; 167: 66316636.
  • 26
    Zhuge X, Arai H, Xu Y et al. Protection of atherogenesis in thromboxane A2 receptor-deficient mice is not associated with thromboxane A2 receptor in bone marrow-derived cells. Biochem Biophys Res Commun 2006; 351: 865871.
  • 27
    Flavahan NA. Balancing prostanoid activity in the human vascular system. Trends Pharmacol Sci 2007; 28: 106110.
  • 28
    Bresalier RS, Sandler RS, Quan H et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 2005; 352: 10921102.
  • 29
    Farkouh ME, Greenberg JD, Jeger RV et al. Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib. Ann Rheum Dis 2007; 66: 764770.
  • 30
    Weiss HJ, Witte LD, Kaplan KL et al. Heterogeneity in storage pool deficiency: studies on granule-bound substances in 18 patients including variants deficient in alpha-granules, platelet factor 4, beta-thromboglobulin, and platelet-derived growth factor. Blood 1979; 54: 12961319.
  • 31
    Von Hundelshausen P, Weber KS, Huo Y et al. RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation 2001; 103: 17721777.
  • 32
    Clemetson KJ, Clemetson JM, Proudfoot AE, Power CA, Baggiolini M, Wells TN. Functional expression of CCR1, CCR3, CCR4, and CXCR4 chemokine receptors on human platelets. Blood 2000; 96: 40464054.
  • 33
    VanWijk MJ, VanBavel E, Sturk A, Nieuwland R. Microparticles in cardiovascular diseases. Cardiovasc Res 2003; 59: 277287.
  • 34
    Wolf P. The nature and significance of platelet products in human plasma. Br J Haematol 1967; 13: 269288.
  • 35
    Barry OP, Pratico D, Savani RC, FitzGerald GA. Modulation of monocyte-endothelial cell interactions by platelet microparticles. J Clin Invest 1998; 102: 136144.
  • 36
    Forlow SB, McEver RP, Nollert MU. Leukocyte-leukocyte interactions mediated by platelet microparticles under flow. Blood 2000; 95: 13171323.
  • 37
    Hrachovinova I, Cambien B, Hafezi-Moghadam A et al. Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A. Nat Med 2003; 9: 10201025.
  • 38
    Sims PJ, Faioni EM, Wiedmer T, Shattil SJ. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 1988; 263: 1820518212.
  • 39
    McCrae KR, Shattil SJ, Cines DB. Platelet activation induces increased Fc gamma receptor expression. J Immunol 1990; 144: 39203927.
  • 40
    Chen H, Marjan J, Cox AD, Devine DV. Characteristics of a novel low affinity complement C3dg-binding protein of human platelets. J Immunol 1994; 152: 13321338.
  • 41
    Coppinger JA, Cagney G, Toomey S et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 2004; 103: 20962104.
  • 42
    Del Conde I, Cruz MA, Zhang H, Lopez JA, Afshar-Kharghan V. Platelet activation leads to activation and propagation of the complement system. J Exp Med 2005; 201: 871879.
  • 43
    Ekdahl KN, Nilsson B. Alterations in C3 activation and binding caused by phosphorylation by a casein kinase released from activated human platelets. J Immunol 1999; 162: 74267433.
  • 44
    Nilsson-Ekdahl K, Nilsson B. Phosphorylation of C3 by a casein kinase released from activated human platelets increases opsonization of immune complexes and binding to complement receptor type 1. Eur J Immunol 2001; 31: 10471054.
  • 45
    Danese S, De La Motte C, Sturm A et al. Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients. Gastroenterology 2003; 124: 12491264.
  • 46
    Danese S, Fiocchi C. Platelet activation and the CD40/CD40 ligand pathway: mechanisms and implications for human disease. Crit Rev Immunol 2005; 25: 103121.
  • 47
    Khandoga A, Hanschen M, Kessler JS, Krombach F. CD4+ T cells contribute to postischemic liver injury in mice by interacting with sinusoidal endothelium and platelets. Hepatology 2006; 43: 306315.
  • 48
    Iannacone M, Sitia G, Ruggeri ZM, Guidotti LG. HBV pathogenesis in animal models: Recent advances on the role of platelets. J Hepatol 2007; 46: 719726.
  • 49
    Elzey BD, Grant JF, Sinn HW, Nieswandt B, Waldschmidt TJ, Ratliff TL. Cooperation between platelet-derived CD154 and CD4+ T cells for enhanced germinal center formation. J Leukoc Biol 2005; 78: 8084.
  • 50
    Hilf N, Singh-Jasuja H, Schwarzmaier P, Gouttefangeas C, Rammensee HG, Schild H. Human platelets express heat shock protein receptors and regulate dendritic cell maturation. Blood 2002; 99: 36763682.
  • 51
    Katoh N, Soga F, Nara T et al. Effect of serotonin on the differentiation of human monocytes into dendritic cells. Clin Exp Immunol 2006; 146: 354361.
  • 52
    Czapiga M, Kirk AD, Lekstrom-Himes J. Platelets deliver costimulatory signals to antigen-presenting cells: A potential bridge between injury and immune activation. Exp Hematol 2004; 32: 135139.
  • 53
    Kobie JJ, Shah PR, Yang L, Rebhahn JA, Fowell DJ, Mosmann TR. T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5′-adenosine monophosphate to adenosine. J Immunol 2006; 177: 67806786.
  • 54
    Deaglio S, Dwyer KM, Gao W et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 2007; 204: 12571265.
  • 55
    Hillebrands JL, Onuta G, Rozing J. Role of progenitor cells in transplant arteriosclerosis. Trends Cardiovasc Med 2005; 15: 18.
  • 56
    Mitchell RN, Libby P. Vascular remodeling in transplant vasculopathy. Circ Res 2007; 100: 967978.